MyFinsight
Home
Blog
About
Comprehensive loss
-$200,976K
(-47.70%↓ Y/Y)
Net loss
-$198,762K
(-47.92%↓ Y/Y)
Unrealized gain on
available-for-sale securities, net
-$1,770K
(-107.99%↓ Y/Y)
Foreign currency
translation adjustments
-$444K
(47.89%↑ Y/Y)
Interest and other
income, net
$13,941K
(7.23%↑ Y/Y)
Net Product Revenue
$25,334K
Collaboration Revenues
$3,290K
(36.18%↑ Y/Y)
Change in fair value of
liabilities related to rpi...
$2,400K
(116.44%↑ Y/Y)
Operating loss
-$179,172K
(-60.68%↓ Y/Y)
Non-cash interest
expense on liabilities...
$20,177K
(53.08%↑ Y/Y)
Total revenues
$28,624K
(-57.13%↓ Y/Y)
Interest and other
expense, net
$14,654K
Change in fair value of
derivative liabilities
-$1,100K
(-136.67%↓ Y/Y)
Total operating
expenses
$207,796K
(16.56%↑ Y/Y)
Selling, general and
administrative
$104,397K
Research and development
$97,807K
(-13.10%↓ Y/Y)
Collaboration cost of sales
$2,861K
Cost of goods sold
$2,731K
Back
Back
Income Statement
CYTK_BIG
source: myfinsight.com
CYTOKINETICS INC (CYTK)
CYTK_BIG
CYTOKINETICS INC (CYTK)